2,059
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats

, , , , , & ORCID Icon show all
Pages 1218-1230 | Received 09 Mar 2020, Accepted 27 Jul 2020, Published online: 10 Aug 2020

References

  • Abdellatif AAH, El-Telbany DFA, Zayed G, Al-Sawahli MM. (2019). Hydrogel containing PEG-coated fluconazole nanoparticles with enhanced solubility and antifungal activity. J Pharm Innov 14:112–22.
  • AbdelSamie SM, Kamel AO, Sammour OA, Ibrahim SM. (2016). Terbinafine hydrochloride nanovesicular gel: in vitro characterization, ex vivo permeation and clinical investigation. Eur J Pharm Sci 88:91–100.
  • Aburahma MH, Badr-Eldin SM. (2014). Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin Drug Deliv 11:1865–83.
  • Algandaby MM, Al-Sawahli MM, Ahmed OA, et al. (2016). Curcumin-Zein nanospheres improve liver targeting and antifibrotic activity of curcumin in carbon tetrachloride-induced mice liver fibrosis. J Biomed Nanotechnol 12:1746–57.
  • Baranowski DC, Buchanan B, Dwyer HC, et al. (2018). Penetration and efficacy of transdermal NSAIDs in a model of acute joint inflammation. J Pain Res 11:2809–19.
  • Beutler E, Duron O, Kelly BM. (1963). Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–8.
  • Bird HA. (1987). Clinical experience with tenoxicam: a review. Scand J Rheumatol Suppl 65:102–6.
  • Cevc G, Blume G. (2001). New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 1514:191–205.
  • Cicala C, Morello S, Alfieri A, et al. (2007). Haemostatic imbalance following carrageenan-induced rat paw oedema. Eur J Pharmacol 577:156–61.
  • Cordero JA, Alarcon L, Escribano E, et al. (1997). A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. J Pharm Sci 86:503–8.
  • D’Souza S. (2014). A review of in vitro drug release test methods for nano-sized dosage forms. Adv Pharm 2014:1–12.
  • Das S, Ng WK, Tan RB. (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–51.
  • Di Rosa M, Giroud JP, Willoughby DA. (1971). Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 104:15–29.
  • Dolenc A, Kristl J, Baumgartner S, Planinsek O. (2009). Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm 376:204–12.
  • El-Feky YA, Mostafa DA, Al-Sawahl MM, El-Telbany RFA, et al. (2020). Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits. J Pharm Pharmacol 72:682–98.
  • El-Ghazaly MA, El-Naby DH, Khayyal MT. (2011). The influence of irradiation on the potential chondroprotective effect of aqueous extract of propolis in rats. Int J Radiat Biol 87:254–62.
  • El-Ghazaly MA, Fadel N, Rashed E, et al. (2017). Anti-inflammatory effect of selenium nanoparticles on the inflammation induced in irradiated rats. Can J Physiol Pharmacol 95:101–10.
  • El-Ghazaly MA, Khayyal MT. (1995). The use of aqueous propolis extract against radiation-induced damage. Drugs Exp Clin Res 21:229–36.
  • Elmowafy M, Samy A, Abdelaziz AE, et al. (2017). Polymeric nanoparticles based topical gel of poorly soluble drug: formulation, ex-vivo and in vivo evaluation. Beni-Suef Univ J Basic Appl Sci 6:184–91.
  • Fang JY, Hwang TL, Fang CL, Chiu HC. (2003). In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm 255:153–66.
  • Fernández-Dueñas V, Sánchez S, Planas E, Poveda R. (2008). Adjuvant effect of caffeine on acetylsalicylic acid anti-nociception: prostaglandin E2 synthesis determination in carrageenan-induced peripheral inflammation in rat. Eur J Pain 12:157–63.
  • Ghasemiyeh P, Mohammadi-Samani S. (2018). Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci 13:288–303.
  • Goindi S, Narula M, Kalra A. (2016). Microemulsion-based topical hydrogels of tenoxicam for treatment of arthritis. AAPS PharmSciTech 17:597–606.
  • Gonzalez JP, Todd PA. (1987). Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 34:289–310.
  • Hashem FM, Al-Sawahli MM, Nasr M, Ahmed OA. (2015). Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems-enhancement of oral bioavailability. Drug Des Devel Ther 9:3141–52.
  • Heng D, Cutler DJ, Chan HK, et al. (2008). What is a suitable dissolution method for drug nanoparticles? Pharm Res 25:1696–701.
  • Hou D, Xie C, Huang K, Zhu C. (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 24:1781–5.
  • Karadzovska D, Brooks JD, Riviere JE. (2013). Modeling the effect of experimental variables on the in vitro permeation of six model compounds across porcine skin. Int J Pharm 443:58–67.
  • Kereškényiová E, Šmajda B. (2004). Endogenous opioids and analgesic effects of ionizing radiation in rats. Acta Vet Brno 73:195–9.
  • Khayyal MT, El-Ghazaly MA, El-Hazek RM, Nada AS. (2009). The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats. Inflammopharmacology 17:255–66.
  • Khurana S, Jain NK, Bedi PM. (2015). Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation. Drug Dev Ind Pharm 41:1368–75.
  • Kurakula M, Ahmed OA, Fahmy UA, Ahmed TA. (2016). Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. J Liposome Res 26:288–96.
  • Miranda KM, Espey MG, Wink DA. (2001). A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71.
  • Mishra V, Bansal KK, Verma A, et al. (2018). Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics 10:191.
  • Muller RH, Keck CM. (2004). Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113:151–70.
  • Negi LM, Jaggi M, Talegaonkar S. (2014). Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int J Pharm 461:403–10.
  • Oka Y, Ibuki T, Matsumura K, et al. (2007). Interleukin-6 is a candidate molecule that transmits inflammatory information to the CNS. Neuroscience 145:530–8.
  • Ou Z, Zhao J, Zhu L, et al. (2019). Anti-inflammatory effect and potential mechanism of betulinic acid on λ-carrageenan-induced paw edema in mice. Biomed Pharmacother 118:109347.
  • Pawar S, Pande V. (2015). Oleic acid coated gelatin nanoparticles impregnated gel for sustained delivery of zaltoprofen: formulation and textural characterization. Adv Pharm Bull 5:537–48.
  • Qi H, Chen W, Huang C, et al. (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 337:178–87.
  • Ragab FA, Heiba HI, El-Gazzar MG, et al. (2017). Anti-inflammatory, analgesic and COX-2 inhibitory activity of novel thiadiazoles in irradiated rats. J Photochem Photobiol B, Biol 166:285–300.
  • Randall LO, Selitto JJ. (1957). A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111:409–19.
  • Reeves GI. (1999). Radiation injuries. Crit Care Clin 15:457–73.
  • Salerno C, Carlucci AM, Bregni C. (2010). Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech 11:986–93.
  • Sarangi B, Jana U, Palei NN, et al. (2019). Solid lipid nanoparticles: a potential approach for drug delivery system. Nanosci Nanotechnol Asia 9:142–56.
  • Shah H, Nair AB, Shah J, et al. (2019). Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats. DARU J Pharm Sci 27:59–70.
  • Sharma RK, Sharma N, Rana S, Shivkumar HG. (2013). Solid lipid nanoparticles as a carrier of matformin for transdermal delivery. Int J Drug Deliv 5:137–45.
  • Shen J, Burgess DJ. (2013). In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug Deliv Transl Res 3:409–15.
  • Şimşek G, Gürocak S, Karadaǧ N, et al. (2012). Protective effects of resveratrol on salivary gland damage induced by total body irradiation in rats. Laryngoscope 122:2743–8.
  • Suleyman H, Halici Z, Cadirci E, et al. (2008). Indirect role of beta2-adrenergic receptors in the mechanism of anti-inflammatory action of NSAIDS. J Physiol Pharmacol 59:661–72.
  • Trocha PJ, Catravas GN. (1980). Catravas, prostaglandin levels and lysosomal enzyme activities in irradiated rats. Int J Radiat Biol Relat Stud Phys Chem Med 38:503–11.
  • Uchiyama M, Mihara M. (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271–8.
  • Vazquez E, Navarro M, Salazar Y, et al. (2015). Systemic changes following carrageenan-induced paw inflammation in rats. Inflamm Res 64:333–42.
  • Vinegar R, Schreiber W, Hugo R. (1969). Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther 166:96–103.
  • Winter CA, Risley EA, Nuss GW. (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111:544–7.
  • Yamaguchi Y, Usami T, Natsume H, et al. (1997). Evaluation of skin permeability of drugs by newly prepared polymer membranes. Chem Pharm Bull 45:537–41.
  • Zayed G. (2014). Dissolution rate enhancement of ketoprofen by surface solid dispersion with colloidal silicon dioxide. UJPB 2:33–8.
  • Zayed MG, El-Feky GS. (2019). Growth factor loaded functionalized gold nanoparticles as potential targeted treatment for acute renal failure. Int J Appl Pharm 11:66–70.
  • Zucoloto AZ, Manchope MF, Staurengo-Ferrari L, et al. (2017). Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects. Inflamm Res 66:591–602.